COSMIN database

What issues matter most to people with multiple myeloma and how well are we measuring them? A systematic review of quality of life tools

Osborne, T. R., Ramsenthaler, C., Siegert, R. J., Edmonds, P. M., Schey, S. A., and Higginson, I. J.
INTRODUCTION: Treatment advances in multiple myeloma have increased expected survival from months to years for some patients. Alongside improved survival emerges a need to better understand and measure health-related quality of life (HRQOL), both in research and clinical settings.

OBJECTIVES: (i) Identify HRQOL tools validated for use in myeloma; (ii) identify issues important to HRQOL from the point of view of patients with myeloma; (iii) describe the measurement properties of each HRQOL tool; (iv) evaluate the content validity of HRQOL tools in terms of their ability to capture all issues important to patients and (v) explore the suitability of each HRQOL tool for use in different settings.

METHOD: Systematic literature review of six databases with no limits by date or language.

RESULTS: Thirty-nine studies reported validation of 13 HRQOL instruments. Seven studies identified issues important to HRQOL from the patients' perspective. No instrument was comprehensive to all issues important to patients. The EORTC-QLQ-C30 and MY24 have undergone the most comprehensive psychometric validation. Most validation occurred in trial patients and not clinically representative groups. No studies evaluated clinical utility of tools alongside routine practice.

CONCLUSION: The best existing HRQOL tools are designed predominantly for use in research. Reliable, valid and responsive tools exist for this purpose, but may miss issues important to patients. The design of HRQOL measures should be guided by intended utility, whether for research or clinical practice, and further validation of HRQOL tools in clinically representative groups is needed. Development and validation of HRQOL tools for clinical use may be of value
Eur.J Haematol.
Publication year:
General health perceptions / HRQoL:
Health-related quality of life
Adults (18-65)
Children (0-18)
Seniors (65+)
Neoplasms and related symptoms
PRO / non-PRO:
Patient Reported Outcome
Type of measurement instrument:
1 - Questionnaires
2 - Interviews
15D - 15-Dimensional Health-Related Quality Of Life Measure   Proqolid blue crop
EORTC QLQ-C30 - European Organization for Research and Treatment of Cancer Quality of Life Questionnaires Core-30 item (ALSO shortened version)   Logozuyd
EORTC-QLQ-HDC19 - European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire – high-dose chemotherapy
EORTC-QLQ-MY24/MY20 - European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire –myeloma module
EQ-5D - EuroQoL-5 Dimensions   Logozuyd
FACT-An - Functional Assessment of Cancer Therapy-Anemia
FACT-BMT - Functional Assessment of Cancer Therapy-Bone Marrow Transplant
LIP - Life ingredient profile
QLI - Quality of Life Index [alias: Ferrans and Powers Quality of Life Index]
SEIQoLDW - Schedule for the Evaluation of Individual Quality Of Life-Direct Weighting
SF-12 - 12-item Short Form Health Survey [alias: RAND-12]
SF-36 - 36-item Short Form Health Survey [alias: RAND-36][alias: Medical Outcomes Study (MOS) SF-36]]   Proqolid blue crop | Logozuyd | also see: